Skip to content

13F-HR/A filed by Camber Capital Management LP

Camber Capital Management LP filed this 13F-HR/A for the quarter ended 2020-09-30, filed 2020-11-16, with 35 holding rows worth $1,895,842,000.

Accession
0001654954-20-012510
Filed
2020-11-16
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2020

A combination report, 35 entries on the cover page, a total value of $1,895,842,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,895,842,000 with VALUE read as thousands by filing date, 13F file number 028-13745. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
CHANGE HEALTHCARE INC15912K100COM15,000,000$217,650,000thousands by filing date
MYLAN NVN59465109SHS EURO12,000,000$177,960,000thousands by filing date
ALEXION PHARMACEUTICALS INC015351109COM1,300,000$148,759,000thousands by filing date
PERRIGO CO PLC SHSG97822103Stock2,850,000$130,844,000thousands by filing date
UNIVERSAL HLTH SVCS INC CL B913903100Stock1,150,000$123,073,000thousands by filing date
ALKERMES PLCG01767105SHS7,250,000$120,133,000thousands by filing date
HCA Healthcare Inc40412C101COM725,000$90,393,000thousands by filing date
BAUSCH HEALTH COS INC COM071734107Stock4,500,000$69,930,000thousands by filing date
IRONWOOD PHARMACEUTICALS INC46333X108COMMON STOCK7,250,000$65,214,000thousands by filing date
MYRIAD GENETICS INC62855J104COM5,000,000$65,200,000thousands by filing date
SAREPTA THERAPEUTICS INC803607100COM425,000$59,683,000thousands by filing date
BLUEBIRD BIO INC09609G100COM1,100,000$59,345,000thousands by filing date
PACIFIC BIOSCIENCES CALIF IN06404D908COM4,410,000$43,527,000thousands by filing date
Cigna Corporation125523100COM250,000$42,353,000thousands by filing date
COLLEGIUM PHARMACEUTICAL INC19459J104COM2,000,000$41,640,000thousands by filing date
NEKTAR THERAPEUTICS640268108COM2,500,000$41,475,000thousands by filing date
AMAG PHARMACEUTICALS INC00163U106COM4,390,000$41,266,000thousands by filing date
TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS881624209ADR4,500,000$40,545,000thousands by filing date
COHERUS ONCOLOGY INC19249H103COM2,200,000$40,348,000thousands by filing date
BROOKDALE SR LIVING INC112463104COM15,000,000$38,100,000thousands by filing date
ORASURE TECHNOLOGIES INC68554V108COM2,750,000$33,468,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM400,000$30,432,000thousands by filing date
PUMA BIOTECHNOLOGY INC74587V107COMMON STOCK2,555,000$25,780,000thousands by filing date
TENET HEALTHCARE CORP COM NEW88033G407Stock1,000,000$24,510,000thousands by filing date
RADIUS HEALTH INC750469207COM NEW2,075,000$23,531,000thousands by filing date
TECTONIC THERAPEUTIC INC COM05455M100Stock1,800,000$23,436,000thousands by filing date
ATARA BIOTHERAPEUTICS INC COM NEW046513107Stock1,400,000$18,144,000thousands by filing date
GLAXOSMITHKLINE PLC-ADR37733W105SPONSORED ADR450,000$16,938,000thousands by filing date
IMMUNOVANT INC45258J102COM438,800$15,441,000thousands by filing date
DICERNA PHARMACEUTICALS INC253031108COM525,000$9,445,000thousands by filing date
GLYCOMIMETICS INC38000Q102COM2,500,000$7,675,000thousands by filing date
SUTRO BIOPHARMA INC869367102COM600,000$6,030,000thousands by filing date
GLOBAL BLOOD THERAPEUTICS USD37890U108COM50,000$2,757,000thousands by filing date
VIR BIOTECHNOLOGY INC92764N102COM16,464$565,000thousands by filing date
ANGIODYNAMICS INC03475V101COM20,876$252,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001654954-20-012412 superseded2020-11-16acceptance time not in the bulk data set
13F-HR/A 0001654954-20-012510this filing2020-11-16acceptance time not in the bulk data set